The interaction between pain and mental disorders: An interdisciplinary analysis through bibliometrics

Abstract

The evolving research on the interactions between pain and mental disorders underscores the critical role of neuroimmune interplay in shaping pain perception and mental illness progression. This study employs bibliometric analysis to scrutinize the research landscape, identify emerging hotspots, and forecast future directions. A systematic review of literature from 2014 to 2023 was conducted using CiteSpace software for co-citation analysis, keyword co-occurrence, and burst detection to identify research hotspots and trends. The study examined developmental trends in pain and psychiatric disorder research, highlighting major research institutions and key themes. It unveils pivotal contributors and collaborative networks, showing significant growth in recent years. Emphasis is placed on neuroinflammation and neuroimmunomodulation interactions with mental illnesses. Keyword and thematic clustering analyses highlight the roles of microglial activation, inflammatory mediators, neurotransmitters, and emotional regulation processes. This study paves the way for future inquiries into neuroimmune mechanisms, the development of personalized treatment strategies, and an interdisciplinary approach to enrich our understanding of the biopsychosocial model in these conditions. Future studies should delve deeper into the molecular intricacies of these interactions to develop more effective therapeutic strategies, aiming to enhance patients' quality of life.

Keywords

bibliometrics / mental illness / neuroimmune interactions / pain

References

[1] Sawicki CM, Humeidan ML, Sheridan JF. Neuroimmune interactions in pain and stress: an interdisciplinary approach. Neuroscientist. 2021; 27(2):113-128.

[2] Jin MY, Everett ES, Abd-Elsayed A. Microbiological and physiological effects of pain. Curr Pain Headache Rep. 2023; 27(6):165-173.

[3] Li C, Huang B, Zhang YW. Chinese herbal medicine for the treatment of depression: effects on the neuroendocrine-immune network. Pharmaceuticals. 2021; 14(1):65.

[4] Hore Z, Denk F. Neuroimmune interactions in chronic pain - an interdisciplinary perspective. Brain Behav Immun. 2019; 79:56-62.

[5] Vojvodic J, Mihajlovic G, Vojvodic P, et al. The impact of immunological factors on depression treatment - relation between antidepressants and immunomodulation agents. Open Access Maced J Med Sci. 2019; 7(18):3064-3069.

[6] Fonseca MM, Davoli-Ferreira M, Santa-Cecília F, et al. IL-27 counteracts neuropathic pain development through induction of IL-10. Front Immunol. 2020; 10:3059.

[7] Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10(4):287.

[8] Allison DJ, Thomas A, Beaudry K, Ditor DS. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. J Neuroinflammation. 2016; 13(1):152.

[9] Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015; 105(3):1809-1831.

[10] Guo R, Xu J, Li C, Mo C, Ou M. Visualizing and analyzing global knowledge maps and emerging research trends in tumor-derived exosomes using CiteSpace. Discover Oncol. 2025; 16(1):1623.

[11] Shen J, Shen H, Ke L, et al. Knowledge mapping of immunotherapy for hepatocellular carcinoma: a bibliometric study. Front Immunol. 2022; 13:815575.

[12] Lin Y, Ren X, Chen D. Steroid treatment in macular edema: a bibliometric study and visualization analysis. Front Pharmacol. 2022; 13:824790.

[13] Zahedi E, Sanaeierad A, Nikbakhtzadeh M, Roghani M, Zamani E. Simvastatin improves learning and memory impairment via gut-brain axis regulation in an ovariectomized/D-galactose Alzheimer's rat model. Behav Brain Res. 2023; 453:114611.

[14] Zahedi E, Sadr SS, Sanaeierad A, Roghani M. Chronic acetyl-L-carnitine treatment alleviates behavioral deficits and neuroinflammation through enhancing microbiota derived-SCFA in valproate model of autism. Biomed Pharmacother. 2023; 163:114848.

[15] Khaleghi-Mehr M, Delshad AA, Shafie-Damavandi S, Roghani M. Metformin mitigates amyloid β(1-40)-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation. Metab Brain Dis. 2023; 38(4):1127-1142.

[16] Jugait S, Areti A, Nellaiappan K, et al. Neuroprotective effect of baicalein against oxaliplatin-induced peripheral neuropathy: impact on oxidative stress, neuro-inflammation and WNT/β-catenin signaling. Mol Neurobiol. 2022; 59(7):4334-4350.

[17] Tranter JD, Kumar A, Nair VK, Sah R. Mechanosensing in metabolism. Comprehensive Physiol. 2024; 14(1):5269-5290.

[18] Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021; 17(3):157-172.

[19] Yang QQ, Li HN, Zhang ST, et al. Red nucleus IL-6 mediates the maintenance of neuropathic pain by inducing the productions of TNF-α and IL-1β through the JAK2/STAT3 and ERK signaling pathways. Neuropathology. 2020; 40(4):347-357.

[20] Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025; 10(1):190.

[21] Silva Santos Ribeiro P, Willemen HLDM, Eijkelkamp N. Mitochondria and sensory processing in inflammatory and neuropathic pain. Frontiers Pain Res. 2022; 3:1013577.

[22] Yao C, Zhang Y, Lu P, et al. Exploring the bidirectional relationship between pain and mental disorders: a comprehensive Mendelian randomization study. J Headache Pain. 2023; 24(1):82.

[23] Pal S, Nath S, Meininger CJ, Gashev AA. Emerging roles of mast cells in the regulation of lymphatic immuno-physiology. Front Immunol. 2020; 11:1234.

[24] Li WW, Guo TZ, Liang D, Sun Y, Kingery WS, Clark JD. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology. 2012; 116(4):882-895.

[25] Bourke SL, Schlag AK, O'Sullivan SE, Nutt DJ, Finn DP. Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research. Pharmacol Ther. 2022; 240:108216.

[26] Warwick CA, Keyes AL, Woodruff TM, Usachev YM. The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain. J Biol Chem. 2021; 297(3):101085.

[27] De Logu F, Boccella S, Guida F. Editorial: the role of neuroinflammation in chronic pain development and maintenance. Front Pharmacol. 2021; 12:821534.

[28] Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017; 38(1):5-19.

[29] Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018; 129(2):343-366.

[30] Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018; 100(6):1292-1311.

[31] Inoue K, Tsuda M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat Rev Neurosci. 2018; 19(3):138-152.

[32] Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487.

[33] Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol. 2018; 14:450-464.

[34] Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2018; 141(7):1917-1933.

[35] Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014; 14(4):217-231.

[36] Heneka MT, Carson MJ, Khoury JE, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405.

[37] Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017; 3:17002.

[38] Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010; 120(11):3779-3787.

[39] Tinnirello A, Mazzoleni S, Santi C. Chronic pain in the elderly: mechanisms and distinctive features. Biomolecules. 2021; 11(8):1256.

[40] Yam MF, Loh YC, Tan CS, Khadijah Adam S, Abdul Manan N, Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018; 19(8):2164.

[41] Kraev K, Geneva-Popova M, Hristov B, et al. Exploring the novel dimension of immune interactions in pain: JAK inhibitors' pleiotropic potential. Life. 2023; 13(10):1994.

[42] Bayraktaroglu I, Ortí-Casañ N, Van Dam D, De Deyn PP, Eisel ULM. Systemic inflammation as a central player in the initiation and development of Alzheimer's disease. Immunity Ageing. 2025; 22(1):33.

[43] Brezic N, Gligorevic S, Sic A, Knezevic NN. Protein misfolding and aggregation as a mechanistic link between chronic pain and neurodegenerative diseases. Curr Issues Mol Biol. 2025; 47(4):259.

[44] Tanaka M, Toldi J, Vécsei L. Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines. Int J Mol Sci. 2020; 21(7):2431.

[45] Alqahtani T, Deore SL, Kide AA, et al. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis - an updated review. Mitochondrion. 2023; 71:83-92.

[46] Abadin X, de Dios C, Zubillaga M, et al. Neuroinflammation in age-related neurodegenerative diseases: role of mitochondrial oxidative stress. Antioxidants. 2024; 13(12):1440.

[47] Yao K, Wang S, Xu Z, et al. Mechanisms of comorbidity between Alzheimer's disease and pain. Alzheimer's Dementia. 2025; 21(2):e14605.

[48] Moubarak MM, Pagano Zottola AC, Larrieu CM, Cuvellier S, Daubon T, Martin OCB. Exploring the multifaceted role of NRF2 in brain physiology and cancer: a comprehensive review. Neuro-oncol Adv. 2024; 6(1):vdad160.

[49] Torta R, Ieraci V, Zizzi F. A review of the emotional aspects of neuropathic pain: from comorbidity to co-pathogenesis. Pain Ther. 2017; 6(suppl 1):11-17.

[50] Hooten WM. Chronic pain and mental health disorders. Mayo Clin Proc. 2016; 91(7):955-970.

[51] Nedic Erjavec G, Konjevod M, Nikolac Perkovic M, et al. Short overview on metabolomic approach and redox changes in psychiatric disorders. Redox Biol. 2018; 14:178-186.

[52] Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 2011; 12(9):964-973.

[53] Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol. 2001; 13(12):1009-1023.

[54] Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci. 2014; 8:447.

[55] Zhu X, Tang HD, Dong WY, et al. Distinct thalamocortical circuits underlie allodynia induced by tissue injury and by depression-like states. Nat Neurosci. 2021; 24(4):542-553.

[56] Sun Z, Wang J, Luo F. Interaction between pain and attention: bottom-up capture vs. top-down modulation. Adv Psychol Sci. 2015; 23(12):2096.

[57] Schoth DE, Godwin HJ, Liversedge SP, Liossi C. Eye movements during visual search for emotional faces in individuals with chronic headache. Eur J Pain. 2015; 19(5):722-732.

[58] Yang Z, Jackson T, Chen H. Effects of chronic pain and pain-related fear on orienting and maintenance of attention: an eye movement study. J Pain. 2013; 14(10):1148-1157.

[59] Lautenbacher S, Spernal J, Schreiber W, Krieg JC. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med. 1999; 61(6):822-827.

[60] Chen D, Yang H, Yang L, et al. Preoperative psychological symptoms and chronic postsurgical pain: analysis of the prospective China surgery and anaesthesia cohort study. Br J Anaesth. 2024; 132(2):359-371.

[61] Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003; 163(20):2433-2445.

[62] Wang W, Qi WJ, Xu Y, Wang JY, Luo F. The differential effects of depression on evoked and spontaneous pain behaviors in olfactory bulbectomized rats. Neurosci Lett. 2010; 472(2):143-147.

[63] Kim Y, Huh I, Kim J, et al. Integration of traditional and metabolomics biomarkers identifies prognostic metabolites for predicting responsiveness to nutritional intervention against oxidative stress and inflammation. Nutrients. 2017; 9(3):233.

[64] Rosario D, Boren J, Uhlen M, et al. Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases. Front Neurosci. 2020; 14:716.

RIGHTS & PERMISSIONS

2025 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University and Wiley-VCH GmbH.